TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25512434

Group type: EXPERIMENTAL
Intervention: Intracoronary sodium nitrite (10 mL, 1.8 μmol)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intracoronary sodium nitrite (10 mL, 1.8 μmol) in a subgroup of 66 patients with thrombolysis in myocardial infarction ≤1 flow
Number of subjects: 80
Study: 24413426

Group type: EXPERIMENTAL
Intervention: Nutritive sucking stimulus (maternal breastfeeding)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking stimulus (researcher's little finger)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no analgesia stimulus)
Number of subjects: 64
Study: 21396638

Group type: EXPERIMENTAL
Intervention: Conventional endoscopy
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Videocapsule endoscopy (VCE)
Number of subjects: 189

Group type: COMPARATOR
Intervention: CT-enteroclysis
Number of subjects: 189
Study: 18675877

Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg)
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Circadian typology
Number of subjects: 688
Study: 16541115

Group type: EXPERIMENTAL
Intervention: Tadalafil treatment
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 49
Study: 14647214

Group type: EXPERIMENTAL
Intervention: Hydrothermally treated barley porridge (28 mg P as InsP(3)-InsP(6))
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control porridge (111 mg P as InsP(3)-InsP(6))
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Breakfast cereals of malted barley (70 mg P as InsP(3)-InsP(6))
Number of subjects: 22

Group type: COMPARATOR
Intervention: Flakes of barley (108 mg P as InsP(3)-InsP(6), no phytase activity)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Hydrothermally treated barley porridge
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control porridge
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Breakfast cereals of malted barley
Number of subjects: 22

Group type: COMPARATOR
Intervention: Flakes of barley
Number of subjects: 22
Study: 10812819

Group type: EXPERIMENTAL
Intervention: Shanvac-B (Group B; n = 59)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Engerix-B (Group A; n = 61)
Number of subjects: 120
Study: 8995025

Group type: EXPERIMENTAL
Intervention: rhGH 0.5 i.u./kg/week
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: rhGH 1.0 i.u./kg/week
Number of subjects: 106
Study: 1600704

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine
Number of subjects: 34
Study: 4091239

Group type: EXPERIMENTAL
Intervention: Etomidate (loading dose of 1 mg/kg b.w. within 15 minutes followed by continuous infusion of 1 mg/kg b.w./h until the end of ECC)
Number of subjects: 506

Group type: COMPARATOR
Intervention: Control group (patients without etomidate)
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 506

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 506
Study: 31627337

Group type: EXPERIMENTAL
Intervention: CoMMIT program plus standard care
Number of subjects: 375

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 375
Study: 29464674

Group type: EXPERIMENTAL
Intervention: One-back task (secondary task)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Predictive learning task
Number of subjects: 0
Study: 27348231

Group type: EXPERIMENTAL
Intervention: Aflibercept (Eylea®), a loading dose of three monthly injections (2 mg/0.05 ml) every 4 weeks for the first 3 months, followed by intravitreal injections every 2 months
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Aflibercept (Eylea®)
Number of subjects: 32
Study: 24807339

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (400 micrograms every 3 hours after 800 micrograms vaginal loading dose)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 micrograms every 4 hours after 800 micrograms vaginal loading dose)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 micrograms every 3 hours after 800 micrograms vaginal loading dose)
Number of subjects: 302
Study: 22229954

Group type: EXPERIMENTAL
Intervention: King Laryngeal Tube (KLT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Endotracheal Intubation (ETI)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Preference
Number of subjects: 25
Study: 20560409

Group type: EXPERIMENTAL
Intervention: Group training (90-min sessions, twice a week for 12 weeks)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Group training
Number of subjects: 86
Study: 16916339

Group type: EXPERIMENTAL
Intervention: SFC (100/50 microg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 15315964

Group type: EXPERIMENTAL
Intervention: ABVD + RT (6 cycles of doxorubicin, bleomycin, vinblastine, dacarbazine followed by radiation therapy)
Number of subjects: 152

Group type: COMPARATOR
Intervention: ABVD alone (6 cycles of doxorubicin, bleomycin, vinblastine, dacarbazine)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: ABVD + RT
Number of subjects: 152

Group type: COMPARATOR
Intervention: ABVD alone
Number of subjects: 152
Study: 10903600

Group type: EXPERIMENTAL
Intervention: Beta-blockers (propranolol)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Sclerotherapy
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Surgical group (portal blood flow-preserving procedures)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Comparison of all three groups
Number of subjects: 119
Study: 9291744

Group type: EXPERIMENTAL
Intervention: Topical lidocaine adrenaline tetracaine (LAT gel)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Injectable buffered lidocaine
Number of subjects: 66
Study: 8318444

Group type: EXPERIMENTAL
Intervention: Shock exposure during acquisition trials
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Startle reflex potentiation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Skin conductance response
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Learning course for startle reflex and skin conductance
Number of subjects: 60
Study: 3518526

Group type: EXPERIMENTAL
Intervention: Cladosporium herbarum preparation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Histamine placebo
Number of subjects: 30
Study: 29504488

Group type: EXPERIMENTAL
Intervention: In-home remote activity monitoring (RAM) system
Number of subjects: 30
Study: 30962230

Group type: EXPERIMENTAL
Intervention: Free-choice multimodule stress management programme (intervention group A)
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Internet cognitive behavioural therapy (iCBT) fixed-order stress management (intervention group B)
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 1080
Study: 27573387

Group type: EXPERIMENTAL
Intervention: 30% trisodium citrate (TSC30%)
Number of subjects: 464
Study: 26501683

Group type: EXPERIMENTAL
Intervention: Treadmill exercise testing
Number of subjects: 15

Group type: COMPARATOR
Intervention: Cycle exercise testing
Number of subjects: 15
Study: 22874091

Group type: EXPERIMENTAL
Intervention: Anterior‐posterior upper cervical mobilization (APUCM)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 21338801

Group type: EXPERIMENTAL
Intervention: bovine somatotropin (bST) treatment
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Induced lactation (estradiol-17β and progesterone)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Induced lactation
Number of subjects: 32
Study: 18397338

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CACE estimators using multiple imputation methods
Number of subjects: 0
Study: 17267589

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Number of subjects: 49
Study: 15839861

Group type: EXPERIMENTAL
Intervention: Ceridal lipolotion instilled in the ear canal with a syringe once a week for 12 months
Number of subjects: 39

Group type: COMPARATOR
Intervention: No intervention (earwax removal only)
Number of subjects: 39
Study: 12161767

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 10218362

Group type: EXPERIMENTAL
Intervention: Mupirocin ointment (2 ml, three times a day for three days)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 7838039

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide/doxorubicin (Cy/A)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Cisplatin/teniposide (P1/VM)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Event free survival
Number of subjects: 134

Group type: COMPARATOR
Intervention: Overall survival
Number of subjects: 134
Study: 2141743

Group type: EXPERIMENTAL
Intervention: Ibuprofen as a supplement to conservative treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo as a supplement to conservative treatment
Number of subjects: 42
Study: 158003

Group type: EXPERIMENTAL
Intervention: Powder face mask with 1.19% clindamycin phosphate in 70% ethanol applied once daily for 5 days
Number of subjects: 29

Group type: COMPARATOR
Intervention: Solution with 1.19% clindamycin phosphate in 70% ethanol applied once daily for 5 days
Number of subjects: 29

Group type: COMPARATOR
Intervention: Powder face mask without clindamycin phosphate applied once daily for 5 days
Number of subjects: 29
Study: 31350270

Group type: EXPERIMENTAL
Intervention: peficitinib 100 mg once daily
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: peficitinib 150 mg once daily
Number of subjects: 507

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 507
Study: 28683231

Group type: EXPERIMENTAL
Intervention: Sound-intensity feedback during running
Number of subjects: 14
Study: 26044715

Group type: EXPERIMENTAL
Intervention: Newborn Infection Control and Care Initiative (NICCI) intervention, which includes infection control in health facilities, promoting infection prevention practices, and improving referral timeliness.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 23504137

Group type: EXPERIMENTAL
Intervention: Multi‐modality adjuvant therapy
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Single‐modality adjuvant therapy
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Surgery only
Number of subjects: 180

Group type: COMPARATOR
Intervention: Matched controls (non‐cancer group)
Number of subjects: 180
Study: 21503263

Group type: EXPERIMENTAL
Intervention: Tiotropium (a once‐daily inhaled anticholinergic)
Number of subjects: 0
Study: 19364166

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (GBE) 240 mg x d(‐1)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (GBE)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 16765287

Group type: EXPERIMENTAL
Intervention: HIV-negative women with HIV-positive partners
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: HIV-positive participants with HIV-positive partners
Number of subjects: 349

Group type: COMPARATOR
Intervention: HIV-negative women
Number of subjects: 349
Study: 14657447

Group type: EXPERIMENTAL
Intervention: Semantic treatment
Number of subjects: 58

Group type: COMPARATOR
Intervention: Phonological treatment
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 11521809

Group type: EXPERIMENTAL
Intervention: Surgery plus radiotherapy (299 patients)
Number of subjects: 579

Group type: COMPARATOR
Intervention: Surgery alone (280 patients)
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Surgery plus radiotherapy
Number of subjects: 579
Study: 9988898

Group type: EXPERIMENTAL
Intervention: AMO 2 x 1000 mg/day (group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ACA 2 x 1250 mg/day (group B)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: OME + AZI treatment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Side effects
Number of subjects: 100
Study: 7816518

Group type: EXPERIMENTAL
Intervention: Direct biochemical analysis of chorionic villus biopsies
Number of subjects: 7
Study: 2718921

Group type: EXPERIMENTAL
Intervention: Diet providing 1 g ascorbic acid/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diet limiting ascorbic acid to about 20 mg/d
Number of subjects: 0
Study: 956519

Group type: EXPERIMENTAL
Intervention: Full view photographic slides
Number of subjects: 30

Group type: COMPARATOR
Intervention: Portrait view slides
Number of subjects: 30
Study: 30411201

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the medial PFC
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 100
Study: 28991332

Group type: EXPERIMENTAL
Intervention: AT LISA tri group (32 eyes)
Number of subjects: 52

Group type: COMPARATOR
Intervention: AT LISA group (38 eyes)
Number of subjects: 52

Group type: COMPARATOR
Intervention: ReSTOR group (34 eyes)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Trifocal and bifocal groups
Number of subjects: 52
Study: 25969531

Group type: EXPERIMENTAL
Intervention: 6 months of antituberculosis therapy using intermittent directly observed therapy (DOTs)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: 9 months of antituberculosis therapy using intermittent directly observed therapy (DOTs)
Number of subjects: 197
Study: 23342782

Group type: EXPERIMENTAL
Intervention: Basic acupuncture
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Cotton moxibustion
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Fire needle
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Tapping‐cupping
Number of subjects: 189

Group type: COMPARATOR
Intervention: Medication (Valaciclovir Hydrochlordide and vitamin B1)
Number of subjects: 189
Study: 20891044

Group type: EXPERIMENTAL
Intervention: Cernilton (two doses, specific dosages not mentioned)
Number of subjects: 0
Study: 18558274

Group type: EXPERIMENTAL
Intervention: C7‐T1 manipulation on the dominant side
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: C7‐T1 manipulation on the nondominant side
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo group (sham‐manual procedure)
Number of subjects: 30
Study: 15857084

Group type: EXPERIMENTAL
Intervention: Ultrasonic bactericidal curettage (UBC) with an ultrasonic scaler
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Hand instrumentation
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: CO2 laser treatment after hand instrumentation
Number of subjects: 33
Study: 11973484

Group type: EXPERIMENTAL
Intervention: 99mTc-DTPA aerosol inhalation scintigraphy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Pulmonary function tests (PFT)
Number of subjects: 26
Study: 10714276

Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 50% oxygen
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (pre-bypass levels)
Number of subjects: 39
Study: 8562664

Group type: EXPERIMENTAL
Intervention: Acute intravenous clomipramine infusion
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Chronic oral clomipramine treatment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Patients who worsened after clomipramine infusion
Number of subjects: 28
Study: 1669517

Group type: COMPARATOR
Intervention: Decreased caloric intake alone
Number of subjects: 872

Group type: COMPARATOR
Intervention: Diet and exercise
Number of subjects: 872

Group type: COMPARATOR
Intervention: Limiting caloric intake
Number of subjects: 872

Group type: COMPARATOR
Intervention: Multifactor intervention (weight reduction, sodium and alcohol intake reduction, increased physical activity)
Number of subjects: 872
Study: 6762807

Group type: EXPERIMENTAL
Intervention: Tienilic acid
Number of subjects: 11

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 11
Study: 31585544

Group type: EXPERIMENTAL
Intervention: FENO group (asthma treatment guided by FENO plus symptoms)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care group (asthma treatment guided by symptoms only)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: FENO group
Number of subjects: 100
Study: 27589252

Group type: EXPERIMENTAL
Intervention: IDegLira
Number of subjects: 435
Study: 25524401

Group type: EXPERIMENTAL
Intervention: Phlebotomy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control
Number of subjects: 74
Study: 23283828

Group type: EXPERIMENTAL
Intervention: Hair removal prior to ear surgery
Number of subjects: 136

Group type: COMPARATOR
Intervention: No hair removal prior to ear surgery
Number of subjects: 136
Study: 22800982

Group type: EXPERIMENTAL
Intervention: Brief Pain Inventory (BPI)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: PEG (3-item abbreviated version of BPI)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: SF-36 pain scale
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Pain global rating of change measure
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Composite measures (BPI total, PEG, SF-36 pain)
Number of subjects: 274
Study: 19397224

Group type: EXPERIMENTAL
Intervention: Antioxidant therapy (daily combination of vitamin E 800 IU, vitamin C 250 mg, vitamin B6 100 mg, vitamin B12 250 mcg, folic acid 10 mg) for 8 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 37
Study: 17963429

Group type: EXPERIMENTAL
Intervention: Piperine 20mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 16856571

Group type: COMPARATOR
Intervention: Nicorandil (NCR) administered intravenously (4 mg) via intracoronary injection (2 mg) or continuously (4 mg/h) in poor flow patients.
Number of subjects: 68

Group type: COMPARATOR
Intervention: Nicorandil (NCR) administered in good flow patients.
Number of subjects: 68
Study: 12589717

Group type: EXPERIMENTAL
Intervention: 3-D computer animation visualization of TMJ sounds and mandibular motion
Number of subjects: 6
Study: 10639305

Group type: EXPERIMENTAL
Intervention: Symptom-limited exercise test
Number of subjects: 395

Group type: COMPARATOR
Intervention: No exercise test
Number of subjects: 395
Study: 9251423

Group type: EXPERIMENTAL
Intervention: 1 gm P2AM single bolus dose at admission followed by placebo infusion over the next 4 days
Number of subjects: 72

Group type: COMPARATOR
Intervention: 12 gm P2AM as a continuous infusion over the next 4 days
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 1 gm P2AM within 12 hours of ingestion
Number of subjects: 72

Group type: COMPARATOR
Intervention: P2AM after 12 hours of ingestion
Number of subjects: 72
Study: 1531383

Group type: EXPERIMENTAL
Intervention: Intrathecal midazolam (2 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Epidural methyl prednisolone (80 mg)
Number of subjects: 28
Study: 6088395

Group type: EXPERIMENTAL
Intervention: 30 g intravenous immunoglobulin divided into three doses per therapy course for infection prophylaxis (Group A)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (Group B) receiving identical chemoradiotherapy without immunoglobulin therapy
Number of subjects: 32
Study: 31964402

Group type: EXPERIMENTAL
Intervention: Cross-sectoral rehabilitation programme
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 118
Study: 30721985

Group type: EXPERIMENTAL
Intervention: Reactive balance training (exposures to slips and trips) - 3 sessions of 40 minutes each (total 120 minutes) over 2 days
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham training - 1 session of 40 minutes
Number of subjects: 44
Study: 28061753

Group type: EXPERIMENTAL
Intervention: Azithromycin 1 g single dose
Number of subjects: 700

Group type: COMPARATOR
Intervention: Doxycycline 100 mg twice daily for 7 days
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 700
Study: 26010418

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (≥180 seconds after delivery)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Early cord clamping (≤10 seconds after delivery)
Number of subjects: 382
Study: 23328000

Group type: EXPERIMENTAL
Intervention: Metformin 1000mg daily
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30mg daily
Number of subjects: 91
Study: 20651694

Group type: EXPERIMENTAL
Intervention: NIDCAP (experimental group, E=12)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care (control group, C=18)
Number of subjects: 30
Study: 19835676

Group type: EXPERIMENTAL
Intervention: Tailored educational intervention on depression using a modified version of the Prochaska stages of change model
Number of subjects: 192

Group type: COMPARATOR
Intervention: Standard continuing medical education
Number of subjects: 192
Study: 16723884

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (loading 10 mg/kg followed by 30 mg/kg daily)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Nimodipine (48 mg/d)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 104

Group type: COMPARATOR
Intervention: Nimodipine
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate and Nimodipine
Number of subjects: 104
Study: 14981369

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Colposuspension
Number of subjects: 344
Study: 11758626

Group type: EXPERIMENTAL
Intervention: Diabetes shared care
Number of subjects: 183
Study: 9237086

Group type: EXPERIMENTAL
Intervention: Acute laboratory challenge
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute laboratory challenge with adjustments for hemoconcentration
Number of subjects: 0
Study: 8481256

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined indomethacin and thymopentin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional postoperative therapy
Number of subjects: 60
Study: 2942618

Group type: EXPERIMENTAL
Intervention: Spinal manipulation in the cervical spine
Number of subjects: 3

Group type: COMPARATOR
Intervention: Sham maneuver with no dynamic thrust
Number of subjects: 3

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 3
Study: 29450866

Group type: EXPERIMENTAL
Intervention: Balanced medial plus lateral wall decompression (MLD)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Single lateral decompression (LD)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both techniques (LD and MLD)
Number of subjects: 38